Field Medical External Stakeholders: Episode 2 Partnering with Patient Advocacy Organizations
This MAPS podcast details potential areas for compliant collaboration by MSLs with Patient Advocacy Groups.
This MAPS podcast details potential areas for compliant collaboration by MSLs with Patient Advocacy Groups.
A Q&A with David Williams, Chief Medical Officer, VISFO
Since its publication in the journal of Therapeutic Innovation & Regulatory Science in July, the article “Promoting Best Practices for Medical Science Liaisons Position Statement from the APPA, IFAPP, MAPS and MSLS,” has been read more than 4000 times. This article presents highlights from a recent MAPS webinar with the paper’s authors, focusing on further defining the role and best practices for Medical Science Liaisons.
This MAPS podcast details potential areas for compliant collaboration by MSLs with key external partners.
Episodes 1-18 of the MAPS Field Medical Focus Area Working Group podcast series, “Field Medical Stakeholders: Partnering for Today and Tomorrow”
This MAPS podcast details strategic opportunities of compliant collaborations between Field Medical and Marketing Development.
This MAPS podcast details strategic opportunities of compliant collaborations between Field Medical and Marketing.
This position paper is intended outline the roles and responsibilities expected of an MSL and provide clarity on the juxtaposition of MSLs and Sales representatives (SRs) when it comes to scientific exchange versus promotional messaging.
This special edition of the MAPS Field Medical podcast series features four global leaders in MSL excellence sharing their subject matter expertise on MSL capabilities.
In this episode of Partnering for Today and Tomorrow we discuss the functions and activities of key internal partners and how we identify potential areas for compliant collaboration by MSLs with key internal partners.
602 Park Point Drive, Suite 225, Golden, CO 80401 – +1 303.495.2073
© 2024 Medical Affairs Professional Society (MAPS). All Rights Reserved Worldwide.